Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Spinal Analgesic Drug Delivery for Ehlers-Danlos Hypermobility Type Chronic Pain Treatment: A Case Report

Van Tilburg CWJ*
Consultant Anesthesiologist and Pain Specialist, Department of Anesthesiology, Bravis hospital, The Netherlands
*Corresponding Author : Cornelis W. J. van Tilburg
MD, FIPP, Consultant Anesthesiologist and Pain Specialist
Multidisciplinary pain center, Department of Anesthesiology
Bravis hospital, Boerhaaveplein 1, 4624 VT Bergen op Zoom, The Netherlands
Tel: 0031-887067697
Fax: 0031 887067699
E-mail: vtilburg@ziggo.nl
Received: January 17, 2016; Accepted: January 17, 2016; Published: February 26, 2016
Citation: Van Tilburg CWJ (2016) Spinal Analgesic Drug Delivery for Ehlers-Danlos Hypermobility Type Chronic Pain Treatment: A Case Report. J Pain Relief 5:235. doi:10.4172/2167-0846.1000235
Copyright: © 2016 Van Tilburg CWJ. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Study background: Chronic pain in patients with Ehlers-Danlos hypermobility type can be a severe, debilitating disorder. Scientific literature on pain treatment in these patients is scarce. We present a case report on spinal analgesic drug delivery for diminishing pain. Methods: Multidisciplinary consultation in adult female patient with Ehlers-Danlos, hypermobility type. Implanting Synchromed® II pump (Medtronic, Minneapolis, MN, United States of America) after successful trial period. One year follow-up. Results: During the trial period, verbal Numerical Rating Scale decreased from 8 to 3 with 0.72 mg of spinal morphine (2 mg/mL, 0.36 mL/day) and no oral or transdermal opioids. The spinal morphine/hydromorphone infusion schemes and verbal NRS for pain after implantation are presented. Baseline and follow-up results at one year from the other questionnaires are presented. Wound healing was successful. Conclusion: Spinal analgesic drug delivery can be an option to treat chronic, widespread pain in patients with Ehlers-Danlos syndrome, hypermobility type. Multidisciplinary consultation is necessary to deal with the wide variety of problems in these patients

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 1556

Journal of Pain & Relief received 1556 citations as per Google Scholar report

Journal of Pain & Relief peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Cosmos IF
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
Top